Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
about
The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5AActivation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders.Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis CHost Gene Expression Profiling of Dengue Virus Infection in Cell Lines and PatientsDifferential Expression of the CXCR3 Ligands in Chronic Hepatitis C Virus (HCV) Infection and Their Modulation by HCV In VitroRole of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infectionZebrafish as a potential model organism for drug test against hepatitis C virusPRMT5-Mediated Methylation of NF-κB p65 at Arg174 Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-α and IFN-γ CostimulationNo increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.The role of chemokines in the recruitment of lymphocytes to the liver.Chemokines in the immunopathogenesis of hepatitis C infectionOsteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.The CXCR3(+)CD56Bright phenotype characterizes a distinct NK cell subset with anti-fibrotic potential that shows dys-regulated activity in hepatitis CThe role of CXCR3 in the induction of primary biliary cirrhosis.Positioning of leukocyte subsets in the portal and lobular compartments of hepatitis C virus-infected liver correlates with local chemokine expression.Detection of allele specific differences in IFNL3 (IL28B) mRNA expressionClinical implications of chemokines in acute and chronic hepatitis C virus infection.Chemokines and their receptors play important roles in the development of hepatocellular carcinomaDelayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis COsteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner.Differential gene expression of primary cultured lymphatic and blood vascular endothelial cells.The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry.High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activityAlanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infectionComparative Analysis of Liver Injury-Associated Cytokines in Acute Hepatitis A and B.Association of IL28B Genotypes and Baseline Serum Interferon-γ-Inducible- Protein-10 Levels with Treatment Response in Hepatitis C Virus Patients in China.The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection.Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.HIV and co-infections.Up-regulation of Plasma Hexosylceramide (d18: 1/18: 1) Contributes to Genotype 2 Virus Replication in Chronic Hepatitis C: A 20-Year Cohort StudyImmune responses during acute and chronic infection with hepatitis C virus.Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.Lymphocyte recruitment and homing to the liver in primary biliary cirrhosis and primary sclerosing cholangitis.Basic concepts of microarrays and potential applications in clinical microbiology.Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients.Adaptive immune response during hepatitis C virus infection.Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.The role of chemokines in acute and chronic hepatitis C infection.The role of chemokines in hepatitis C virus-mediated liver diseaseSignal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus.
P2860
Q24632380-550DA6BE-C4CF-4CF5-AB45-458DB8326A26Q27472760-358FC0FC-51CA-4316-84B7-80E961B4A751Q27480302-86AE8F91-811C-427F-8EDC-1B6EE59AE6E1Q27482207-FCE2711A-E7DA-4FE8-B42D-2C79FBDED86EQ27487530-92B32E2B-519E-4342-A584-71F723814ECFQ27490393-650184A3-0B5A-408A-8082-2370A2A90FAEQ28476465-E3188008-6213-4580-8D94-046AE8A5AAB1Q28550383-A9615C5E-CE90-40E6-AF22-F5A88A785402Q33676594-7E79D90C-C0F2-4B6D-AA54-362E34C8F392Q33906565-EAF68FCF-B4E7-4FBE-BC2F-C66F68B2EE81Q34056271-3600BCA9-0F65-443B-8B23-EFC8CE57D93EQ34255535-0E224DCB-ABD3-4B24-B7D5-718527A1A728Q34335634-7D3346C6-8038-481E-A67F-84088EED9522Q35008551-493242ED-B105-45B0-8313-454EF6C5160BQ35044131-91F0BF80-3618-482C-A53D-07DFBDF8F41EQ35306683-62DE0729-E631-4174-808A-D3029B157D32Q35561908-6A7219CC-41A9-41EE-93E5-52FC0F18F307Q35668771-B9F313BC-FF8C-4C00-A835-93550A0079F4Q35986301-0268774B-41F2-43C9-87CA-74CA7CD5A73AQ36093343-CDC67F01-6AA0-4D52-A637-02BA916E2810Q36267269-20AAE2EB-DCD9-4A0F-AB35-34B455E18537Q36283505-DB960C14-A4B8-4C21-890D-EB7EEFDF3A4DQ36554751-14DE0724-DBD3-4AF8-9D56-2336F15660EFQ36611680-A8CE42A1-FBD6-4FAF-9AE0-93D5B091DA72Q36707912-3BAE5C9C-7F8A-4DE8-899A-946A0A978240Q36848968-708AAA2C-140F-44F2-8623-BB3FBE2ADF67Q36944050-88C52B65-0E1B-454A-9742-6EB3205FB211Q36964114-1C40AF7C-31B4-4D11-96CC-7953FF4C4E9BQ36970184-D1D47D2D-B42A-4A40-832B-00A72AFB1F45Q37003642-34EF585E-3C9D-4824-96FF-0E6E179FF45BQ37178225-98AEECE3-C9C2-42E8-8E25-F09BB1C0C76BQ37300367-BBC081DE-C289-4413-A8D5-3D060795AFD5Q37378198-2350E314-FB45-4660-81E6-8DE205ED18EBQ37409999-03B18B10-6530-4748-AAA7-ADA4594A88B0Q37571093-1947C133-7D7C-405B-A2F5-1273D4FD22DBQ37682489-2208B878-7890-4A77-A18B-BD0138B65BFFQ37683158-610B2F0C-1D3A-433B-B4DC-9CFD321F0CD9Q38129709-1A7B4787-DE62-40F4-B33C-CEF426E332A3Q38197441-39485865-519F-4396-ACC8-867FD71F9017Q39148017-84C554E6-8064-4888-9554-A831FE0E9BAA
P2860
Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Expression of the CXCR3 ligand ...... ion with hepatic inflammation.
@en
type
label
Expression of the CXCR3 ligand ...... ion with hepatic inflammation.
@en
prefLabel
Expression of the CXCR3 ligand ...... ion with hepatic inflammation.
@en
P2093
P2860
P356
P1433
P1476
Expression of the CXCR3 ligand ...... tion with hepatic inflammation
@en
P2093
Andrew Ruszkiewicz
Hugh A J Harley
Ljiljana Semendric
Shaun R McColl
P2860
P304
P356
10.1002/HEP.20167
P407
P577
2004-05-01T00:00:00Z